Topiroxostat
托匹司他
Report date: 2025/12/18 20:00:07
NME
Base Information
Drug NameTopiroxostat
Drug Alias Name +[10]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in ChinaN/A
Original Approved Country/Territory
Original Approved Date2013/06/28
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesFuji Yakuhin Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesHebei Kaiwei Kangling Pharmaceutical CO LTDShanghai Qihang Pharmaceutical Technology Development Co LtdFuji Yakuhin Co Ltd +[6]
Inactive CompaniesGuangzhou Fuji Topi Pharmaceutical Co LtdNanjing Huawe Medicine Technology Group Co LtdBeijing Shenlanhai Biological Medicine Technology Co Ltd
Active Indications
Inactive Indications